HDL Composition Is Profoundly Altered in Patients With Type 2 Diabetes (T2D) and Atherosclerotic Vascular Disease

被引：0
|
作者：
Morgantini, Cecilia
Meriwether, David
Baldi, Simona
Venturi, Elena
Pinnola, Silvia
Fogelman, Alan M.
Ferrannini, Ele
Natali, Andrea
Reddy, Srinivasa T.
机构：
来源：
DIABETES | 2013年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
424-P
引用
收藏
页码：A108 / A109
页数：2
相关论文
共 50 条
  • [1] HDL lipid composition is profoundly altered in patients with type 2 diabetes and atherosclerotic vascular disease
    Morgantini, C.
    Meriwether, D.
    Baldi, S.
    Venturi, E.
    Pinnola, S.
    Wagner, A. C.
    Fogelman, A. M.
    Ferrannini, E.
    Natali, A.
    Reddy, S. T.
    [J]. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2014, 24 (06) : 594 - 599
  • [2] Association of the Sizes and Composition of HDL with Hepatic Steatosis in Adolescents with Type 2 Diabetes (T2D)
    Orozco Morales, Jose Antonio
    Torres Tamayo, Margarita
    Medina Urrutia, Aida
    Juarez Rojas, Juan Gabriel
    Reyes Barrera, Juan
    Jorge Galarza, Esteban
    Dies Suarez, Pilar
    Medina Bravo, Patricia
    [J]. HORMONE RESEARCH IN PAEDIATRICS, 2018, 90 : 229 - 229
  • [3] Children with Type 2 Diabetes (T2D) Have Altered Arginine Metabolism
    Tosur, Mustafa
    Hsu, Jean W.
    Deen, Saima
    Uysal, Serife
    Astudillo, Marcela
    Redondo, Maria J.
    Jahoor, Farook
    Balasubramanyam, Ashok
    [J]. DIABETES, 2022, 71
  • [4] Diabetic Kidney Disease (DKD) in UK Patients With Type 2 Diabetes (T2D)
    Ruzafa, Javier Cid
    Paczkowski, Rosirene
    Boye, Kristina S.
    Di Tanna, Gian Luca
    Sheetz, Matthew J.
    Donaldson, Robert
    Breyer, Matthew D.
    Neasham, David
    Voelker, James R.
    [J]. DIABETES, 2013, 62 : A397 - A397
  • [5] Presence of Type 2 Diabetes (T2D) Affects HDL Particle Proteomic Composition Independently of Obesity or Fatty Liver
    Bril, Fernando
    Pearce, Ryan
    Collier, Timothy S.
    Kalavalapalli, Srilaxmi
    Mcphaul, Michael J.
    Cusi, Kenneth
    [J]. DIABETES, 2022, 71
  • [6] Genomic Data and Disease Forecasting: Application to Type 2 Diabetes (T2D)
    Sirovich, Lawrence
    [J]. PLOS ONE, 2014, 9 (01):
  • [7] Mechanisms of the Antihyperglycemic Effect of Sitagliptin in Patients with Type 2 Diabetes (T2D)
    Muscelli, Elza
    Casolaro, Arturo
    Gastaldelli, Amalia
    Mari, Andrea
    Seghieri, Giuseppe
    Chen, Yu
    Alba, Maria
    Holst, Jens
    Ferrannini, Ele
    [J]. DIABETES, 2011, 60 : A267 - A267
  • [8] Dapagliflozin (DAPA) in Patients with Type 2 Diabetes (T2D) and Mixed Dyslipidemia
    Bays, Harold E.
    Sartipy, Peter
    Xu, John
    Langkilde, Anna Maria
    Sjostrom, C. David
    [J]. DIABETES, 2016, 65 : A306 - A306
  • [9] Diabetes Management in Hospitalized Patients with Type 2 Diabetes (T2D) during Fasting Periods
    Rainer, Raphael
    Elsayed, Hesham
    Aberer, Felix
    Beck, Peter
    Pieber, Thomas R.
    Donsa, Klaus
    Plank, Johannes
    Mader, Julia K.
    [J]. DIABETES, 2018, 67
  • [10] IDegLira Is Efficacious Across the Range of Disease Progression in Type 2 Diabetes (T2D)
    Rodbard, Helena W.
    Buse, John B.
    Woo, Vincent C.
    Vilsboll, Tina
    Langbakke, Irene H.
    Korsholm, Lars
    Gough, Stephen
    [J]. DIABETES, 2014, 63 : A18 - A18
12345